Holdaway KM - Search Results

1

Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer.

Jass JR, Cottier DS, Jeevaratnam P, Pokos V, Holdaway KM, Bowden ML, Van de Water NS, Browett PJ. Jass JR, et al. Among authors: holdaway km. Lancet. 1995 Nov 4;346(8984):1200-1. doi: 10.1016/s0140-6736(95)92902-9. Lancet. 1995. PMID: 7475662

2

Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism.

Baguley BC, Holdaway KM, Thomsen LL, Zhuang L, Zwi LJ. Baguley BC, et al. Among authors: holdaway km. Eur J Cancer. 1991;27(4):482-7. doi: 10.1016/0277-5379(91)90391-p. Eur J Cancer. 1991. PMID: 1827725

3

Cellular responses to methyl-N-[4-9-acridinylamino)-2-methoxyphenyl] carbamate hydrochloride, an analogue of amsacrine active against non-proliferating cells.

Moreland N, Finlay GJ, Dragunow M, Holdaway KM, Baguley BC. Moreland N, et al. Among authors: holdaway km. Eur J Cancer. 1997 Sep;33(10):1668-76. doi: 10.1016/s0959-8049(97)00165-2. Eur J Cancer. 1997. PMID: 9389932

4

Inhibition of growth of primary human tumour cell cultures by a 4-anilinoquinazoline inhibitor of the epidermal growth factor receptor family of tyrosine kinases.

Baguley BC, Marshall ES, Holdaway KM, Rewcastle GW, Denny WA. Baguley BC, et al. Among authors: holdaway km. Eur J Cancer. 1998 Jun;34(7):1086-90. doi: 10.1016/s0959-8049(98)00043-4. Eur J Cancer. 1998. PMID: 9849459

5

Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer.

Baguley BC, Marshall ES, Whittaker JR, Dotchin MC, Nixon J, McCrystal MR, Finlay GJ, Matthews JH, Holdaway KM, van Zijl P. Baguley BC, et al. Among authors: holdaway km. Eur J Cancer. 1995;31A(2):230-7. doi: 10.1016/0959-8049(94)00472-h. Eur J Cancer. 1995. PMID: 7718330

6

The role of immune effector cells in flavone acetic acid-induced injury to tumor cells in EMT6 spheroids.

Zwi LJ, Baguley BC, Gavin JB, Holdaway KM, Wilson WR. Zwi LJ, et al. Among authors: holdaway km. Oncol Res. 1992;4(8-9):333-9. Oncol Res. 1992. PMID: 1486217

7

Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells.

Finlay GJ, Holdaway KM, Baguley BC. Finlay GJ, et al. Among authors: holdaway km. Cancer Chemother Pharmacol. 1994;34(2):159-65. doi: 10.1007/BF00685934. Cancer Chemother Pharmacol. 1994. PMID: 8194167

8

Radiosensitivity of new and established human melanoma cell lines: comparison of [3H]thymidine incorporation and soft agar clonogenic assays.

Marshall ES, Matthews JH, Shaw JH, Nixon J, Tumewu P, Finlay GJ, Holdaway KM, Baguley BC. Marshall ES, et al. Among authors: holdaway km. Eur J Cancer. 1994;30A(9):1370-6. doi: 10.1016/0959-8049(94)90188-0. Eur J Cancer. 1994. PMID: 7999427

9

Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine.

Ferguson LR, Whiteside G, Holdaway KM, Baguley BC. Ferguson LR, et al. Among authors: holdaway km. Environ Mol Mutagen. 1996;27(4):255-62. doi: 10.1002/(SICI)1098-2280(1996)27:4<255::AID-EM2>3.0.CO;2-C. Environ Mol Mutagen. 1996. PMID: 8665870

10

Relationship of cell cycle parameters to in vitro and in vivo chemosensitivity for a series of Lewis lung carcinoma lines.

Holdaway KM, Finlay GJ, Baguley BC. Holdaway KM, et al. Eur J Cancer. 1992;28A(8-9):1427-31. doi: 10.1016/0959-8049(92)90537-c. Eur J Cancer. 1992. PMID: 1515264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page